Specifically for this patient, the following were discussed: firstly, there was still a remnant tumor in an eloquent region of the brain; next, the Ki-67 index was 5%; and lastly, the molecular findings of an NTRK gene fusion included the lack of BRAFV600E mutation and CDKN2A homozygous deletion. Here, CDKN2A is linked to neoplasm.